US 10278374
Genetically modified mice and engraftment
granted A61KA61K49/00
Quick answer
US patent 10278374 (Genetically modified mice and engraftment) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K49/00